Tsai Yuan-Hsin, Tseng Chun-Chieh, Lin Yun-Chan, Nail Howida M, Chiu Kuan-Yu, Chang Yen-Hao, Chang Ming-Wei, Lin Feng-Huei, Wang Hui-Min David
Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung, Taiwan; Department of Orthopedic Surgery, Show-Chwan Memorial Hospital, Changhua, Taiwan.
Metal Industries Research & Development Centre, Kaohsiung, Taiwan; Combination Medical Device Technology Division, Medical Devices R&D Service Department, Metal Industries Research & Development Centre, Kaohsiung, Taiwan.
Biomed J. 2024 Jun 3;48(2):100750. doi: 10.1016/j.bj.2024.100750.
Critical bone defects pose a significant challenge for orthopedic surgeons. Autologous bone grafting is the golden standard. However, it is hindered by issues such as donor site morbidity and limited availability. Commercially available artificial bone grafts may encounter challenges in properly integrating the surrounding bone tissue, potentially leading to delayed or incomplete healing. Furthermore, magnesium deficiency has been shown to negatively affect localized angiogenesis and bone repair. As a result, creating a synthetic biomaterial that includes magnesium could serve as an excellent bone substitute. The study aims to evaluate and test the morphological, mechanical, and biological properties of a calcium phosphate cement (CPC) sponge composed of tetracalcium phosphate (TTCP) and monocalcium phosphate monohydrate (MCPM).
This study aims to develop biomedical materials composed mainly of TTCP and MCPM powder, magnesium powder, and collagen. The materials were prepared using a wet-stirred mill and freeze-dryer methods. The particle size, composition, and microstructure of the materials were investigated. Finally, the biological properties of these materials, including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for biocompatibility, effects on bone cell differentiation by alkaline phosphatase (ALP) activity assay and tartrate-resistant acid phosphatase (TRAP) activity assay, and endothelial cell tube formation assay for angiogenesis, were evaluated as well.
The data showed that the sub-micron CPC powder, composed of TTCP/MCPM in a 3.5:1 ratio, had a setting time shorter than 15 min and a compressive strength of 4.39 ± 0.96 MPa. This reveals that the sub-micron CPC powder had an adequate setting time and mechanical strength. We found that the sub-micron CPC sponge containing magnesium had better biocompatibility, including increased proliferation and osteogenic induction effects without cytotoxicity. The CPC sponge containing magnesium also promoted angiogenesis.
In summary, we introduced a novel CPC sponge, which had a similar property to human bone promoted the biological functions of bone cells, and could serve as a promising material used in bone regeneration for critical bone defects.
严重骨缺损给骨科医生带来了重大挑战。自体骨移植是金标准。然而,它受到供区并发症和可用性有限等问题的阻碍。市售人工骨移植在与周围骨组织正确整合方面可能会遇到挑战,这可能导致愈合延迟或不完全。此外,已表明镁缺乏会对局部血管生成和骨修复产生负面影响。因此,创建一种包含镁的合成生物材料可以作为一种出色的骨替代物。本研究旨在评估和测试由磷酸四钙(TTCP)和磷酸二氢钙一水合物(MCPM)组成的磷酸钙骨水泥(CPC)海绵的形态、力学和生物学特性。
本研究旨在开发主要由TTCP、MCPM粉末、镁粉和胶原蛋白组成的生物医学材料。使用湿式搅拌磨和冷冻干燥机方法制备材料。研究了材料的粒径、组成和微观结构。最后,还评估了这些材料的生物学特性,包括用于生物相容性的3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定、通过碱性磷酸酶(ALP)活性测定和抗酒石酸酸性磷酸酶(TRAP)活性测定对骨细胞分化的影响,以及用于血管生成的内皮细胞管形成测定。
数据表明,由TTCP/MCPM以3.5:1比例组成的亚微米级CPC粉末,凝固时间短于15分钟,抗压强度为4.39±0.96MPa。这表明亚微米级CPC粉末具有足够的凝固时间和机械强度。我们发现含镁的亚微米级CPC海绵具有更好的生物相容性,包括增殖增加和成骨诱导作用且无细胞毒性。含镁的CPC海绵还促进血管生成。
总之,我们引入了一种新型CPC海绵,其性质与人类骨骼相似,促进了骨细胞的生物学功能,可作为用于严重骨缺损骨再生的有前景的材料。